Chelsea Counsel CO Prime Medicine, Inc. Transaction History

Chelsea Counsel CO

$182 Million
Q1 2025

A detailed history of Chelsea Counsel CO transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Chelsea Counsel CO holds 208,210 shares of PRME stock, worth $503,868. This represents 0.23% of its overall portfolio holdings.

Number of Shares

208,210

Previous 186,780 11.47%

Holding current value

$503,868

Previous $545,000 24.04%

% of portfolio

0.23%

Previous 0.28%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 21, 2025	BUY	$1.72 - $3.35 $36,859 - $71,790	21,430 Added 11.47%	208,210 $414,000
Q4 2024 Feb 27, 2025	BUY	$2.64 - $4.46 $285,357 - $482,081	108,090 Added 137.36%	186,780 $545,000
Q3 2024 Nov 21, 2024	BUY	$3.41 - $6.7 $3,410 - $6,700	1,000 Added 1.29%	78,690 $304,000
Q2 2024 Nov 21, 2024	BUY	$4.3 - $8.03 $312,567 - $583,700	72,690 Added 1453.8%	77,690 $399,000
Q4 2023 Feb 21, 2024	BUY	$5.59 - $9.55 $24,596 - $42,020	4,400 Added 733.33%	5,000 $44,000
Q4 2022 Feb 23, 2023	BUY	$15.2 - $21.12 $9,120 - $12,672	600 New	600 $11,000

Others Institutions Holding PRME

# of Institutions

130

Shares Held

57.7M

Call Options Held

12.4K

Put Options Held

107K

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $232M

More about PRME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chelsea Counsel CO, based on Form 13F filings with the SEC.

News

Stay updated on Chelsea Counsel CO with notifications on news.

Account

Chelsea Counsel CO Prime Medicine, Inc. Transaction History